精神科共病对多发性骨髓瘤患者医疗资源利用及医疗费用的影响
该研究基于监测、流行病学和最终结果(SEER)-Medicare数据库,纳入1991至2010年诊断的多发性骨髓瘤(MM)患者,分为仅MM、MM+精神科共病、MM+抑郁三组,分析诊断后前6个月的人口学特征、骨髓瘤定义事件(MDE)、医疗资源利用及费用差异。结果显示精神科共病在女性中更常见、少数族裔患病率较低;MM+精神科共病组和MM+抑郁组所有临床MDE更常见,且精神科诊断在MM后出现者多数MDE更常见;所有治疗场景的医疗资源利用更高,诊断后前6个月费用显著更高,少数族裔合并精神科诊断者费用增加更明显。作者认为精神科共病显著影响MM患者的临床表现、医疗资源利用和费用,需加以解决以改善生存。
要点
- 精神科共病在女性MM患者中更常见,少数族裔精神科共病率较低。
- MM+精神科共病组和MM+抑郁组所有临床MDE更常见,精神科诊断在MM后出现者多数MDE更常见。
- MM+精神科共病组和MM+抑郁组诊断后前6个月医疗费用显著更高,少数族裔合并精神科诊断者费用增加更明显。
核心结论
- 精神科共病显著影响MM患者的临床表现、医疗资源利用和费用,这些发现需加以解决以改善MM患者的生存。
研究设计与样本
- 基于监测、流行病学和最终结果(SEER)-Medicare数据库,纳入1991至2010年诊断的MM患者,分为仅MM、MM+精神科共病(任何精神科疾病,预先存在或MM后发生)、MM+抑郁(抑郁为唯一精神科诊断,预先存在或MM后发生)三组,分析诊断后前6个月的人口学特征、临床骨髓瘤定义事件(MDE)、医疗资源利用(住院、门诊、流动医疗索赔)及医疗费用差异。
主要发现
- 精神科共病在女性中报告更频繁,少数族裔精神科共病率较低。
- 所有临床MDE在MM+精神科共病组和MM+抑郁组更常见;在这些组内,多数MDE在MM后诊断精神科疾病或抑郁的患者中较预先存在者更常见。
- 所有治疗场景的医疗资源利用在伴有精神科共病者中更高。
- MM诊断后前6个月内医疗费用在MM+精神科共病组和MM+抑郁组显著更高。
- 费用增加在诊断为精神科疾病(包括抑郁)的少数族裔患者中更明显。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Approximately one third of cancer patients suffer from comorbid mood disorders that are associated with increased cost and poorer outcomes. The majority of patients with multiple myeloma (MM) are treated with corticosteroids; as many as three fourths of those taking corticosteroids develop neuropsychiatric complications, likely increasing morbidity and cost of care. MM patients diagnosed between 1991 and 2010 and reported in the Surveillance Epidemiology, and End Results-Medicare database were characterized as MM-Only, MM+Psychiatric (any psychiatric condition, preexisting or post-MM), or MM+Depression (depression as the only psychiatric diagnosis, preexisting or post-MM). Differences in demographic characteristics, occurrence of clinical myeloma-defining events (MDEs), health care utilization (inpatient, outpatient, ambulatory claims), and cost of care during the first 6 months of MM diagnosis were analyzed. Psychiatric comorbidities were reported more frequently in females, and racial minorities had lower rates of psychiatric comorbidities. All clinical MDEs were more common in the MM+Psychiatric and MM+Depression groups; within them, the majority were more common in patients diagnosed with the psychiatric condition or depression after MM compared with it being a preexisting condition. Health care utilization in all treatment settings was higher in those with psychiatric comorbidities. Cost of care within the first 6 months after MM diagnosis was significantly higher in the MM+Psychiatric and MM+Depression groups. This increase in cost was more pronounced for patients from racial minorities diagnosed with a psychiatric condition, including depression. Psychiatric comorbidities significantly impact the clinical presentations, health care utilization, and cost among patients with MM. These findings need to be addressed for improved survivorship of MM patients.
引用
- Niazi S, Frank RD, Sharma M, et al. Impact of psychiatric comorbidities on health care utilization and cost of care in multiple myeloma. Blood Adv. 2018. PMID: 29776984. doi:10.1182/bloodadvances.2018016717
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。